We are live on !
Find out more
EntryPoint Capital Portfolio holdings
AUM
$412M
Turnover
50.4%
1-Year Est. Return
28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$70.8M
(+21%)
Cap. Flow
+$36.5M
Cap. Flow % of AUM
Cap. Flow %
8.87%
Top 10 Holdings %
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234
Avg Time Held
0.4
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntington Bancshares
HBAN
|
+$1.67M |
| 2 |
Donaldson
DCI
|
+$1.6M |
| 3 |
FedEx
FDX
|
+$1.6M |
| 4 |
Fidelity National Financial
FNF
|
+$1.53M |
| 5 |
Graco
GGG
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$1.48M |
| 2 |
TIC Solutions Inc
TIC
|
+$1.48M |
| 3 |
Schrodinger
SDGR
|
+$1.27M |
| 4 |
Exelon
EXC
|
+$1.23M |
| 5 |
Visteon
VC
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18% |
| 2 | Financials | 16.8% |
| 3 | Healthcare | 15.07% |
| 4 | Technology | 12.86% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Xeris Biopharma Holdings
XERS
$1.97B
| $640K | 0.16% |
80,750
-15,460
| -16% | -$98.7K |
2024 Q1
9 quarters
|
|
227
Xenia Hotels & Resorts
XHR
$1.81B
| $637K | 0.15% |
31,291
+13,588
| +77% | +$235K |
2026 Q1
1 quarter
|
|
228
Kennametal
KMT
$2.38B
| $635K | 0.15% |
+18,118
| New | +$660K |
2026 Q2
0 quarters
|
|
229
Sturm, Ruger & Co
RGR
$801M
| $634K | 0.15% |
16,754
+1,866
| +13% | +$75K |
2026 Q1
1 quarter
|
|
230
Fermi Inc
FRMI
$1.83B
| $633K | 0.15% |
+69,121
| New | +$437K |
2026 Q2
0 quarters
|
|
231
Clorox
CLX
$10.3B
| $633K | 0.15% |
+6,632
| New | +$637K |
2026 Q2
0 quarters
|
|
232
Alamo Group
ALG
$1.81B
| $629K | 0.15% |
3,825
+951
| +33% | +$154K |
2024 Q2
8 quarters
|
|
233
Ametek
AME
$57.4B
| $629K | 0.15% |
2,600
| – | – |
2025 Q4
2 quarters
|
|
234
Exponent
EXPO
$3.48B
| $629K | 0.15% |
10,705
| – | – |
2026 Q1
1 quarter
|
|
235
BP
BP
$128B
| $629K | 0.15% |
17,010
+9,042
| +113% | +$397K |
2026 Q1
1 quarter
|
|
236
MillerKnoll
MLKN
$1.39B
| $626K | 0.15% |
+30,608
| New | +$490K |
2026 Q2
0 quarters
|
|
237
Host Hotels & Resorts
HST
$17.2B
| $624K | 0.15% |
26,297
-8,684
| -25% | -$194K |
2026 Q1
1 quarter
|
|
238
CBL Properties
CBL
$1.51B
| $623K | 0.15% |
+11,734
| New | +$543K |
2026 Q2
0 quarters
|
|
239
East-West Bancorp
EWBC
$18B
| $623K | 0.15% |
4,823
| – | – |
2025 Q3
3 quarters
|
|
240
Slide Insurance Holdings
SLDE
$3.17B
| $621K | 0.15% |
+32,041
| New | +$580K |
2026 Q2
0 quarters
|
|
241
United Fire Group
UFCS
$1.47B
| $619K | 0.15% |
11,806
| – | – |
2024 Q4
6 quarters
|
|
242
CoStar Group
CSGP
$13.3B
| $616K | 0.15% |
21,757
+1,969
| +10% | +$67.7K |
2025 Q4
2 quarters
|
|
243
Wolverine World Wide
WWW
$1.65B
| $615K | 0.15% |
+37,198
| New | +$629K |
2026 Q2
0 quarters
|
|
244
Forward Air
FWRD
$532M
| $609K | 0.15% |
45,080
+34,701
| +334% | +$517K |
2026 Q1
1 quarter
|
|
245
Idacorp
IDA
$8.02B
| $609K | 0.15% |
4,024
| – | – |
2025 Q3
3 quarters
|
|
246
WD-40
WDFC
$2.58B
| $604K | 0.15% |
2,481
+1,219
| +97% | +$261K |
2025 Q3
3 quarters
|
|
247
Aveanna Healthcare
AVAH
$2.84B
| $603K | 0.15% |
70,397
-48,103
| -41% | -$339K |
2025 Q3
3 quarters
|
|
248
Matrix Service
MTRX
$287M
| $603K | 0.15% |
44,036
+5,215
| +13% | +$67.2K |
2025 Q2
4 quarters
|
|
249
Mirum Pharmaceuticals
MIRM
$5.42B
| $603K | 0.15% |
5,150
| – | – |
2025 Q1
5 quarters
|
|
250
McKesson
MCK
$118B
| $602K | 0.15% |
797
+480
| +151% | +$381K |
2026 Q1
1 quarter
|
|
Similar funds
EntryPoint Capital's Q2 2026 Portfolio in Review
As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.
- EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
- EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
- EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
- EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
- EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
- EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
- EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.